Search Results 2351-2360 of 17237 for Green Birth Control
Individuals regarded as belonging to a vulnerable population (e.g., prisoners). Patients aged 18 years or older. Individuals with HIV or hepatitis infection ...
dehydration, or hypotension. 3. Requires second line treatments (eg, telotristat) for control of carcinoid syndrome symptoms. 4. Treatment with specific NET ...
The patient's body mass index (BMI) is ≥ 97th percentile at recruitment based on the Centers for Disease Control (CDC) charts, and;; The patient has early ...
This randomized, double-blind, placebo-controlled study will assess the efficacy and safety of vismodegib with surgery in patients with basal cell carcinoma.
... management of prostate cancer. Exclusion Criteria: Patients who already received primary treatment or neo-adjuvant therapy. Patients who refuse undergoing ...
This guideline attempts to provide a clinical framework for the management of NMIBC. Read More on PubMed. More about research at Mayo Clinic. Research Faculty ...
Patient 18 years or older with breast cancer and biopsy-proven malignant involvement of an axillary lymph node · Patient is not pregnant. · Surgical management ...
About this study. Integration of Diabetes Prevention Program (DPP) and Diabetes Self Management Program (DSMP) into WellConnect.
This randomized, multicenter, placebo-controlled, double-blind study will evaluate the efficacy and safety of inhaled CVT 301 compared with placebo in PD ...
ovarian cancer awareness ribbons, green. THIS WEEK'S TOP STORIES Ovarian cancer. September is Ovarian Cancer Awareness Month, which makes it a good time to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!